Sign in
Download Opera News App

STOCK INVESTMENT

DiaSorin strikes $1.8 billion Luminex deal to dodge 'COVID cliff'

DiaSorin strikes $1.8 billion Luminex deal to dodge 'COVID cliff'

MILAN (Reuters) -Italian diagnostics firm DiaSorin has agreed to buy U.S. rival Luminex Corp for $1.8 billion in a move that could boost its molecular business and offset a potential drop in demand for COVID-19 tests as the pandemic is brought under control. The pandemic has fuelled rapid growth at Diasorin’s molecular...

Read Full Story
DiaSorin Diasorin Luminex MILAN Reuters Texas-based

Top News

EUROPEAN POLITICS

Election results: Labour braced for tight finish in race for London mayor - as support for Sadiq Khan is squeezed

news.sky.com
Election results: Labour braced for tight finish in race for London mayor - as support for Sadiq Khan is squeezed

EUROPEAN POLITICS

Election results: Labour braced for tight finish in race for London mayor - as support for Sadiq Khan is squeezed

news.sky.com

GOSSIP CELEBRITY

Lily James Is Unrecognisable As She Is Transformed Into Pamela Anderson For New Drama

huffingtonpost.co.uk
Lily James Is Unrecognisable As She Is Transformed Into Pamela Anderson For New Drama

GOSSIP CELEBRITY

Lily James Is Unrecognisable As She Is Transformed Into Pamela Anderson For New Drama

huffingtonpost.co.uk

comments

Load app to read more comments